Apex Biotechnology Stock

Apex Biotechnology Employees 2024

Apex Biotechnology Employees

0

Ticker

1733.TW

ISIN

TW0001733004

In 2024, Apex Biotechnology employed 0 people, a 0% change from the 0 number of employees in the previous year.

Apex Biotechnology Aktienanalyse

What does Apex Biotechnology do?

Apex Biotechnology Corp is a Taiwan-based company specializing in the development of innovative biotechnology products. The company was founded in 2002 and offers a wide range of products and services to its customers. Apex Biotechnology Corp began with the production of specialty chemicals and enzymes for research and development purposes. Over the years, the company has expanded its business and focused on the development of diagnostic products, dietary supplements, and pharmaceutical products. The company's business model focuses on the development and marketing of biotechnology products. Apex Biotechnology Corp has established advanced research centers and works closely with research institutions and pharmaceutical companies worldwide to develop innovative solutions. The company operates in various sectors, including diagnostics, dietary supplements, and pharmaceuticals. It offers a diverse range of products, including enzyme immunoassays, lateral flow tests, dietary supplements, and pharmaceuticals. Apex Biotechnology Corp has built strong relationships with research institutions and pharmaceutical companies and has successfully marketed its products internationally. Apex Biotechnology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Apex Biotechnology's Employee Base

Apex Biotechnology's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Apex Biotechnology's operational capacity and future potential.

Year-to-Year Comparison

Assessing Apex Biotechnology's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Apex Biotechnology's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Apex Biotechnology’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Apex Biotechnology stock

How many employees does Apex Biotechnology have this year?

Apex Biotechnology has 0 undefined employees this year.

How many employees did Apex Biotechnology have compared to the previous year?

Compared to the previous year, Apex Biotechnology had 0% more employees.

What impact did the number of employees have on the company Apex Biotechnology?

The number of employees has a direct impact on the efficiency and productivity of Apex Biotechnology. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Apex Biotechnology?

The number of employees can also have an impact on investors of Apex Biotechnology, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Apex Biotechnology affect the company?

An increase in equity of Apex Biotechnology can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Apex Biotechnology's equity affect the company?

A reduction in equity of Apex Biotechnology can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Apex Biotechnology?

Some factors that can influence the equity of Apex Biotechnology include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Apex Biotechnology so important for investors?

The equity of Apex Biotechnology is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Apex Biotechnology influence the company?

The number of employees at Apex Biotechnology can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Apex Biotechnology evolved in recent years?

In recent years, the number of employees at Apex Biotechnology has changed by NaN.

How many employees does Apex Biotechnology currently have?

Apex Biotechnology currently has 0 undefined employees.

Why is the number of employees important for investors of Apex Biotechnology?

The number of employees is important for investors of Apex Biotechnology as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Apex Biotechnology take to change the number of employees?

To change the number of employees, Apex Biotechnology can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Apex Biotechnology pay?

Over the past 12 months, Apex Biotechnology paid a dividend of 1.4 TWD . This corresponds to a dividend yield of about 4.77 %. For the coming 12 months, Apex Biotechnology is expected to pay a dividend of 1.4 TWD.

What is the dividend yield of Apex Biotechnology?

The current dividend yield of Apex Biotechnology is 4.77 %.

When does Apex Biotechnology pay dividends?

Apex Biotechnology pays a quarterly dividend. This is distributed in the months of September, July, July, June.

How secure is the dividend of Apex Biotechnology?

Apex Biotechnology paid dividends every year for the past 21 years.

What is the dividend of Apex Biotechnology?

For the upcoming 12 months, dividends amounting to 1.4 TWD are expected. This corresponds to a dividend yield of 4.77 %.

In which sector is Apex Biotechnology located?

Apex Biotechnology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Apex Biotechnology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Apex Biotechnology from 6/14/2024 amounting to 1.1 TWD, you needed to have the stock in your portfolio before the ex-date on 5/17/2024.

When did Apex Biotechnology pay the last dividend?

The last dividend was paid out on 6/14/2024.

What was the dividend of Apex Biotechnology in the year 2023?

In the year 2023, Apex Biotechnology distributed 1.3 TWD as dividends.

In which currency does Apex Biotechnology pay out the dividend?

The dividends of Apex Biotechnology are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Apex Biotechnology

Our stock analysis for Apex Biotechnology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Apex Biotechnology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.